Natural Compounds from Plants Targeting Alzheimer’s Disease
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
214-302
Author(s):
Andreia Corciova, Daniela Matei, Calin Corciova and Bianca Ivănescu
Treatment of Diabetic Neuropathy - Current Possibilities and Perspectives
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
227-296
Author(s):
Jarmila Vojtkova, Miriam Ciljakova and Peter Banovcin
Pharmaceutical and Nutritional Benefits in Alzheimer's Disease via Convergence on the Melatoninergic Pathways
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
50-127
Author(s):
George Anderson and Michael Maes
Melatoninergic Pathways in Alzheimer's Disease
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
3-49
Author(s):
George Anderson and Michael Maes
Pharmacotherapies for Alzheimer’s Disease: From Natural Compounds to Target Synthetic Drugs
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
315-366
Author(s):
Chuang Wang, Rui Wang, James M. O’Donnell and Ying Xu
Cognitive Decline and Alzheimer's Disease: A Central Role for Hypoxia-Obstructive Sleep Apnea and Related Stigmata in Elderly
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
265-314
Author(s):
Mak Adam Daulatzai
Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
109-146
Author(s):
Rosaria A. Cavallaro and Andrea Fuso
Immunotherapy with Anti-Aβ Monoclonal Antibodies in Alzheimer’s Disease: A Critical Review on the Molecules in the Pipelines with Regulatory Considerations
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
3-85
Author(s):
Chrystelle Mavoungou and Katharina Schindowski Zimmerman